Medical Pharmaceuticals

¡Participa junto a la American Foundation for Suicide Prevention en la caminata nocturna del Overnight 2023 el 3 de junio en D.C.!

by

NUEVA YORK, 18 de mayo de 2023 /PRNewswire-HISPANIC PR WIRE/ — American Foundation for Suicide Prevention (AFSP), la organización de prevención del suicidio líder del país, organizará su principal evento de recaudación de fondos, la 28.ª caminata nocturna, The Overnight Walk, el 3 de junio de 2023 en Washington, D.C. El suicidio es una de las … Read more

Dr. Andrea Olariu, CEO – Curae Pharma360 Inc. Statement on U.S. House Committee on Energy and Commerce Subcommittee on Oversight and Investigations

by

Curae Pharma360 Applauds the House Energy and Commerce Committee for Examining the Root Causes of Drug Shortages: Challenges in Pharmaceutical Drug Supply Chains SAN FRANCISCO, May 18, 2023 /PRNewswire/ — On May 11, the House Energy and Commerce Committee held a timely and important hearing to identify and raise visibility for the root causes of … Read more

At a CAGR of 6.19% ,Global Joint Reconstruction Market to Grow Exponentially by 2029- Brandessence Market Research

by

LONDON, May 18, 2023 /PRNewswire/ — Joint aches and related disorders are very common, especially among the older adults. Throughout our lives, a high pressure is applied on our joints to carry out various mobility activities which in turn weakens the. Apart from that, accidents and other injuries also lead to joint disorders. With rapid … Read more

Cystic Fibrosis Therapeutics Market to Grow Substantially by 2029

by

LONDON, May 18, 2023 /PRNewswire/ — Cystic fibrosis (CF), a challenging genetic disorder affecting the lungs and digestive system, has experienced remarkable advancements in therapeutics, instilling hope and enhancing the quality of life for those affected. This progressive disease involves the production of thick mucus, chronic lung infections, and compromised digestion. The realm of CF therapeutics … Read more

Inspira™ Technologies Reports First Quarter 2023 Financial Results

by

As of March 31, 2023, the Company had $11.5 million in cash, cash equivalents, and short-term bank deposits RA’ANANA, Israel, May 18, 2023 /PRNewswire/ — Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the “Company” or “Inspira Technologies”), a company aiming to revolutionize acute respiratory care, announced today its financial results for the first quarter ended March … Read more

Navrogen Announces Publication of NAV-001 Antibody-Drug Conjugate Development and Efficacy in Humoral Immunosuppressed Cancers

by

The publication in PLOS ONE shows that NAV-001 has robust single-dose efficacy against multiple mesothelin-expressing cancers and that tumor-produced Humoral Immunology-Oncology (HIO) factors negatively impact antibody drug internalization and efficacy. CHEYNEY, Pa., May 18, 2023 /PRNewswire/ — Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, announces today a publication describing … Read more

Forum Health Doubles Texas Reach with Game-Changing 4 Location Acquisition

by

FLINT, Mich., May 18, 2023 /PRNewswire/ — Forum Health, LLC, the first nationwide network of integrative and functional medicine providers, has acquired Hormones by Design, one of the largest hormone replacement clinic networks in Texas.  Hormones by Design is a renowned healthcare provider specializing in hormone replacement therapy with four Texas locations in Waco, San … Read more

Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit

by

NEW YORK, May 18, 2023 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that Chief Scientific Officer Dr. Miriam Kidron will deliver an in-person presentation at the Novel Therapies for Type 2 Diabetes & Obesity Summit in Boston, MA, on May 31, 2023. The presentation will include an overview of Oramed’s oral … Read more

Affinia Therapeutics Presents New Preclinical Data on Novel AAV Capsids for Skeletal Muscle, Cardiac Muscle, and CNS at the American Society of Gene & Cell Therapy 26TH Annual Meeting

by

WALTHAM, Mass., May 18, 2023 /PRNewswire/ — Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies for both rare and prevalent devastating diseases, today announced the presentation of new preclinical data on novel AAV capsids for skeletal muscle, cardiac muscle, and central nervous system (CNS). This research will be presented in an oral session today at 1:30pm PT … Read more

BridGene Biosciences to Present at Hippo Pathway Targeted Drug Development Summit

by

SAN JOSE, Calif., May 18, 2023 /PRNewswire/ — BridGene Biosciences, Inc., a biotechnology company using a proprietary chemoproteomics technology to discover and develop small molecules for high-value, traditionally undruggable targets, announced that Wolf Wiedemeyer, Ph.D., head of biology at BridGene, will be giving a presentation, titled “A Covalent TEAD Inhibitor with Exceptional Anti-cancer Activity & … Read more